CASTRATION RESISTANT PROSTATIC NEOPLASMS

Clinical trials for CASTRATION RESISTANT PROSTATIC NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new CASTRATION RESISTANT PROSTATIC NEOPLASMS trials appear

Sign up with your email to follow new studies for CASTRATION RESISTANT PROSTATIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Early cancer drug trial halted before full testing

Disease control Terminated

This early-stage study tested a new oral drug called NUV-868, both alone and combined with two existing cancer medications (olaparib or enzalutamide), in adults with advanced solid tumors. The goal was to find safe doses and see if these treatments could help control cancers like…

Matched conditions: CASTRATION RESISTANT PROSTATIC NEOPLASMS

Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control

Last updated Apr 03, 2026 14:41 UTC

CASTRATION RESISTANT PROSTATIC NEOPLASMS

Get alerted when new CASTRATION RESISTANT PROSTATIC NEOPLASMS trials appear

Early cancer drug trial halted before full testing